Feng Ren

Feng Ren

Chief Executive Officer at INSILICO MEDICINE CAYMAN TOPCO

Net worth: 8 M $ as of 2026-07-30

51 year
Consumer Services
Health Technology
Commercial Services

Profile

Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-05 1,288,055 ( 0.22% ) 8 M $ 2026-07-30

Feng Ren active positions

CompaniesPositionStart
INSILICO MEDICINE CAYMAN TOPCO Chief Executive Officer 2022-05-31
Chief Executive Officer -

Former positions of Feng Ren

CompaniesPositionEnd
SHANGHAI MEDICILON INC. Corporate Officer/Principal 2020-12-31
GSK PLC Director/Board Member 2017-12-31
See the detail of Feng Ren's experience

Training of Feng Ren

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Technology Services

Health Technology